Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells
Thomas Efferth, Marco Giaisi, Annette Merling et al. · 2007
Read Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells by Thomas Efferth, Marco Giaisi, Annette Merling et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000693.txt.
Description
Thomas Efferth, Marco Giaisi, Annette Merling and colleagues tested a malaria drug against resistant leukemia cells, in PLOS ONE in 2007. Drug resistance is a major obstacle in cancer treatment, as tumor cells learn to survive chemotherapy. New drugs are urgently needed that hit tumor cells hard while sparing normal cells. Artesunate, a drug known from malaria care, was their candidate.
The title states their finding: artesunate triggers apoptosis, programmed cell death, in T leukemia cells that resist doxorubicin. The killing runs through ROS, reactive oxygen species that damage cells from inside. Repurposing a known drug for resistant cancers could shorten the road to the clinic.
Catalog record
| CREATOR | Thomas Efferth, Marco Giaisi, Annette Merling et al. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000693